PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Comtan, Comtess

What is Entacapone? Entacapone is COMT inhibitor drug which enhances the transport of l-dopa to the brain, improving the efficacy of l-dopa containing drugs such as Sinemet.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

103 patients in the community are taking or have taken Entacapone.

Reason # Patients Percentage of patients
Treat Parkinson's 76 82%
Stiffness/spasticity 6 6%
Other 6 6%
Support another treatment 2 2%
disease-related symptoms 1 1%
Slowness 1 1%

Dosages

Based on the patients currently taking Entacapone.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 1 mg day 20 mg day 200 mg day 300 mg day 400 mg day 600 mg day 800 mg day 900 mg day 1000 mg day 1200 mg day
  9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 14 Number of Patients: 14 4 Number of Patients: 4 8 Number of Patients: 8 17 Number of Patients: 17 24 Number of Patients: 24 1 Number of Patients: 1 7 Number of Patients: 7 2 Number of Patients: 2  

Duration

How long current patients have been taking Entacapone or how long patients were taking Entacapone before stopping.

Currently taking Entacapone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
6
10
13
7
34

Stopped taking Entacapone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
1
2
4
Why Patients Stopped Taking Entacapone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 6 67% Side effects too severe: 67%
Other 5 56% Other: 56%
Did not seem to work 1 11% Did not seem to work: 11%
Doctor's advice 1 11% Doctor's advice: 11%
Course of treatment ended 1 11% Course of treatment ended: 11%

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Slight 50% 1
Can't tell 50% 1

Treat Parkinson's

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 50% 1
None 50% 1

Top reported side-effects include: Increased dyskenisia

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 2)

  • EfficacyCan't tell
  • Side-effectsNone
  • Treat Parkinson's

See all evaluation results for Entacapone



Back to top